GEN Exclusives

More »

GEN News Highlights

More »
Sep 18, 2012

FDA Okays Meridian’s Strep Throat Diagnostic

  • FDA cleared Meridian Bioscience’s illumingene® molecular diagnostic test for Group A Streptococcus pharyngitis. The test, carried out on the illumigene molecular diagnostic platform, uses loop-mediated isothermal DNA amplification to detect Streptococcus pyogenes in throat samples, takes less than an hour to complete, and the kit includes all reagents and disposables that can be stored at room temperature.

    “Our diagnostic tests are specifically developed for faster and more accurate detection and early diagnosis of acute infectious disease-causing pathogens,” states Jack Kraeutler, CEO. “With illumigene Group A Strep, healthcare providers and patients can get a definitive strep throat diagnosis rapidly.”

    Meridian offers a broad range of diagnostic test kits, purified reagents and biopharmaceutical enabling technologies. The firm’s diagnostic portfolio includes tests for the early diagnosis of Clostridium difficile, Helicobacter pylori, foodborne diseases, and respiratory infections. 


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?